Heart Health Check

A 20-biomarker cardiovascular risk panel combining lipid profiling, blood sugar assessment (HbA1c, insulin, fasting glucose), inflammation markers (hs-CRP, homocysteine), and organ function screening. Covers the metabolic, inflammatory, and lipid drivers of atherosclerosis — the process underlying heart attacks and strokes. Heart disease remains the leading cause of death in Australia, responsible for more deaths than any cancer.

The Heart Health Check goes beyond a standard cholesterol test to assess the interconnected metabolic pathways that drive cardiovascular disease. The lipid profile measures total cholesterol, HDL, LDL, triglycerides, and ratios — but lipids tell only part of the story. HbA1c, fasting insulin, and fasting glucose assess metabolic health and insulin resistance — a major but often invisible cardiovascular risk factor. Insulin resistance promotes arterial inflammation, drives triglyceride production, and reduces protective HDL cholesterol, creating a metabolic environment that accelerates atherosclerosis. Homocysteine is an independent cardiovascular risk factor that damages arterial walls and promotes blood clotting. Elevated levels are common and easily treatable with targeted B vitamin supplementation. High-sensitivity CRP measures the arterial inflammation that drives plaque formation and rupture — the event that causes most heart attacks. Liver and kidney function panels are included because both organs play central roles in cholesterol metabolism, blood pressure regulation, and fluid balance. This panel provides the data that cardiovascular risk calculators and preventive cardiologists use to stratify risk and guide intervention.